RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
about
The Intracellular Loop of the Glycine Receptor: It's not all about the SizeThe Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and GlycineA Recombinant Human Pluripotent Stem Cell Line Stably Expressing Halide-Sensitive YFP-I152L for GABAAR and GlyR-Targeted High-Throughput Drug Screening and Toxicity Testing.RNA Editing-Systemic Relevance and Clue to Disease Mechanisms?Zinc-dependent modulation of α2- and α3-glycine receptor subunits by ethanol.Alternative splicing and extensive RNA editing of human TPH2 transcriptsA novel glycine receptor beta subunit splice variant predicts an unorthodox transmembrane topology. Assembly into heteromeric receptor complexesGlycine receptor mutants of the mouse: what are possible routes of inhibitory compensation?Allosteric modulation of glycine receptors.The glycinergic system in human startle disease: a genetic screening approach.Defective glycinergic synaptic transmission in zebrafish motility mutants.The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Post-transcriptional control of Na,K-ATPase activity and cell growth by a splice variant of FXYD2 protein with modified mRNA.Estrogen in cycling rats alters gene expression in the temporomandibular joint, trigeminal ganglia and trigeminal subnucleus caudalis/upper cervical cord junctionGlycine transporter 1 is a target for the treatment of epilepsy.Generation of Functional Inhibitory Synapses Incorporating Defined Combinations of GABA(A) or Glycine Receptor Subunits.Inhibitory glycine receptors: an update.Tranexamic acid concentrations associated with human seizures inhibit glycine receptors.Glycine receptors: recent insights into their structural organization and functional diversity.E-I balance and human diseases - from molecules to networking.Glycine receptor in rat hippocampal and spinal cord neurons as a molecular target for rapid actions of 17-beta-estradiol.Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy.Glycine Receptors Caught between Genome and Proteome - Functional Implications of RNA Editing and Splicing.Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.When you can't trust the DNA: RNA editing changes transcript sequences.Putative impact of RNA editing on drug discovery.Presynaptic mechanisms of neuronal plasticity and their role in epilepsy.Phenotyping Cellular Viability by Functional Analysis of Ion Channels: GlyR-Targeted Screening in NT2-N Cells.Changes in neural network homeostasis trigger neuropsychiatric symptoms.Extrasynaptic and postsynaptic receptors in glycinergic and GABAergic neurotransmission: a division of labor?Comparing methods of detection and quantitation of RNA editing of rat glycine receptor alpha3.Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U EditingThe GlyR Extracellular β8-β9 Loop - A Functional Determinant of Agonist Potency.Functional hallmarks of GABAergic synapse maturation and the diverse roles of neurotrophins.4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance.Parallel Evolution and Lineage-Specific Expansion of RNA Editing in Ctenophores.The M4 transmembrane segment contributes to agonist efficacy differences between alpha1 and alpha3 glycine receptors.Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.Glucose is a positive modulator for the activation of human recombinant glycine receptors.A Novel RNA Editing Sensor Tool and a Specific Agonist Determine Neuronal Protein Expression of RNA-Edited Glycine Receptors and Identify a Genomic APOBEC1 Dimorphism as a New Genetic Risk Factor of Epilepsy.
P2860
Q26743781-266B3F3B-FB26-430C-BE96-34DB6B70A4CCQ26752724-55602195-863A-4D1F-94E7-F8711E41B086Q27308741-A197EC88-2FD1-4175-9075-0FF61417197FQ28079613-62122530-7AA3-470A-B629-E2B728BD8D40Q28115903-8DAB36EC-BCE6-47B4-8420-043D272E7C43Q28272183-CF365F7B-3710-4535-A09B-90D86E265238Q28577129-42EB152A-EA3F-4C22-9FBE-3DA0AF1A15C2Q30461478-F2D6CD80-FD78-4768-A356-9AAF4031EA73Q30464018-C059F423-53F1-4954-86FE-7A19B8710A41Q30481905-C848B679-51A1-4145-B9E1-AB7F77E6C194Q30483303-083ABB48-250E-437F-925E-676423E06EBCQ30486732-289EAE20-AF9C-46A3-AF12-AE09F48B5FB2Q34979144-7C024734-A909-4FCF-BE60-8F565640B2A4Q35032344-D26B6721-91A7-4654-9641-B0E7335B63BAQ36304849-CA45B518-4301-465A-BF51-BF64F76FE816Q36396544-3367F688-0A24-4BD3-9497-63EDC006FD3CQ36418772-D919BE0F-F22C-4C76-B048-56CE221FBFAEQ36498021-6DE63856-7146-4739-A103-06470ABA33BFQ36521927-BA7B26AA-9D46-4D0E-88E1-51462CA4A53BQ36852893-398F7360-D499-4FC6-8712-8E6A2DFD91F5Q37117223-34EDF599-8E26-411E-A9B7-0916DD733973Q37310739-0DD3881B-1259-4117-A217-520C264B71AFQ37425291-D25BEAA1-FD5D-408B-BF05-25F3849633BEQ37699484-F2A0A7D6-7F59-4644-B100-C508820D7406Q37799569-31B128F7-E390-4D24-B4F4-69C290B6980CQ38068563-8A3FCE8D-356B-405D-B27D-ADF06B00E83FQ38225535-ED38C840-4061-443F-BB6A-A55079E26C22Q38805667-502AC928-2771-430E-9B2A-1F173DCF6544Q41895985-180AC8C5-7711-4F5C-9978-3C439C833400Q41986225-AA89FBA4-F975-427A-AD5E-DA2DCE992CF9Q42096824-5D533006-C330-42DC-ACEB-7EBDCEA2F210Q42211038-E2959586-5A0B-46F5-ACFA-3532BAADFA39Q42698547-04B61BF7-94CD-4308-B833-0EB0FA3EDACEQ42789979-80E98B8E-E026-4C6E-8226-8822EAC62AECQ43101508-0EC82CC3-5E81-4533-AA58-CB415034FE5CQ43399540-82298870-F3C6-49BA-8576-EED72D8E6802Q43684699-C591FF7C-926D-41B5-99CF-E5AFC4AE47EFQ46086074-C938AB13-A30E-4383-B27B-A3F4C4F6F1D1Q46754612-CEE1D33C-E00C-432D-A83D-AC00EDBC8041Q47836651-4EFD6D44-668A-424D-B9D0-32DC40639A32
P2860
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@en
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@nl
type
label
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@en
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@nl
prefLabel
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@en
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@nl
P2093
P2860
P50
P356
P1433
P1476
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
@en
P2093
Christian Henneberger
Claudia Racca
Igor Melnick
Rosemarie Grantyn
Volker Schmieden
P2860
P2888
P304
P356
10.1038/NN1467
P407
P577
2005-05-15T00:00:00Z